Biotechnology Stocks I Performance Guide: Harmony Biosciences Holdings, Inc. (HRMY)
HRMY has no dividends
Table and Chart of HRMY Performance
See what a $1,000 investment in HRMY is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| HRMY Returns | |
|---|---|
| Start Date | Sep-30-2020 |
| Start Price | $33.90 |
| End Date | Dec-01-2023 |
| End Price | $30.48 |
| # Prices | 40 |
| Min Date | Oct-31-2023 |
| Min Price | $23.54 |
| Max Date | Nov-30-2022 |
| Max Price | $59.77 |
| Total Return | -10.09% |
| Annualized Return | -3.14% |
| Current Value of $1,000 Purchase | $899 |
| Number Returns | 780 |
| Average Return | 4.86% |
| Number Profitable Returns | 405 |
| Percent Profitable Returns | 51.92% |
| Number Unprofitable Returns | 375 |
| Percent Unprofitable Returns | 48.08% |
| Profitable to Unprofitable Returns Ratio | 1.08 |
| HRMY Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $1,785,271,000 | Price to Sales | 3.29 |
| Earnings per Share | $2.4700 |
| PE Ratio | 12.34 |
| PE to Growth Ratio | None |
| Price to Book | 3.714 |
| PRICE DATA | |
| 52 Week High | $61.42 |
| 52 Week Low | $18.61 |
| Analyst Target Price | $40.78 |
| 50-Day Moving Average | $26.95 |
| 200-Day Moving Average | $33.86 |
| FINANCIAL DATA | |
| Revenue per Share | $9.07 |
| Revenue | $541,918,000 |
| Profit Margin | 27.8% |
| Return on Equity | 0.365% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
HRMY Compare Returns with S&P 500
HRMY Trendline Chart